AI Verdict
HIMS has stronger fundamentals based on our AI analysis.
HIND vs HIMS Fundamental Comparison
| Metric | HIND | HIMS |
|---|---|---|
| Revenue | $319,714.0 | $2.3B |
| Net Income | $-10.3M | $128.4M |
| Net Margin | -3,209.7% | 5.5% |
| ROE | -272.8% | 23.7% |
| ROA | -157.9% | 6.0% |
| Current Ratio | 1.99x | 1.90x |
| Debt/Equity | 0.80x | 0.00x |
| EPS | $-4.86 | $0.51 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HIND vs HIMS: Frequently Asked Questions
Is HIND or HIMS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HIMS has stronger fundamentals. HIND is rated STRONG SELL (88% confidence) while HIMS is rated BUY (72% confidence). This is not investment advice.
How does HIND compare to HIMS fundamentally?
Vyome Holdings, Inc has ROE of -272.8% vs Hims & Hers Health, Inc.'s 23.7%. Net margins are -3,209.7% vs 5.5% respectively.
Which stock pays higher dividends, HIND or HIMS?
HIND has a dividend yield of N/A or no dividend while HIMS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HIND or HIMS for long term?
For long-term investing, consider that HIND has STRONG SELL rating with 88% confidence, while HIMS has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HIND vs HIMS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HIND vs HIMS, the AI consensus favors HIMS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.